Patienter bør overvåges nøje i den periode, hvor der skiftes fra buprenorphin eller metadon til Suboxone, da der har været rapporteret abstinenssymptomer.
Patients should be closely monitored during the switching period from buprenorphine or methadone to Suboxone since withdrawal symptoms have been reported.